PD-L1 is frequently overexpressed in cancers such as lung, bladder, breast, and stomach cancers, and its high levels correlate with poor prognosis (Parry et al. 2005; Thompson et al. 2004; Ohaegbulam et al. 2015). Here, CD274 is linked to cancer.